Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and Non-Mucinous Histologies

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2024 Apr 9

PMID 38594579

Authors

Vasileios Tsagkalidis

Jennie K Choe

Toni Beninato

Mariam F Eskander

Miral S Grandhi

Haejin In

Timothy J Kennedy

Russell C Langan

Jason C Maggi

Henry A Pitt

H Richard Alexander

Brett L Ecker

Affiliations

Soon will be listed here.

Abstract

Background: Mucinous appendiceal adenocarcinomas (MAA) and non-mucinous appendiceal adenocarcinomas (NMAA) demonstrate differences in rates and patterns of recurrence, which may inform the appropriate extent of surgical resection (i.e., appendectomy versus colectomy). The impact of extent of resection on disease-specific survival (DSS) for each histologic subtype was assessed.

Patients And Methods: Patients with resected, non-metastatic MAA and NMAA were identified in the Surveillance, Epidemiology, and End Results database (2000-2020). Multivariable models were created to examine predictors of colectomy for each histologic subtype. DSS was calculated using Kaplan-Meier estimates and examined using Cox proportional hazards modeling.

Results: Among 4674 patients (MAA: n = 1990, 42.6%; NMAA: n = 2684, 57.4%), the majority (67.8%) underwent colectomy. Among colectomy patients, the rate of nodal positivity increased with higher T-stage (MAA: T1: 4.6%, T2: 4.0%, T3: 17.1%, T4: 21.6%, p < 0.001; NMAA: T1: 6.8%, T2: 11.4%, T3: 25.6%, T4: 43.8%, p < 0.001) and higher tumor grade (MAA: well differentiated: 7.7%, moderately differentiated: 19.2%, and poorly differentiated: 31.3%; NMAA: well differentiated: 9.0%, moderately differentiated: 20.5%, and 44.4%; p < 0.001). Nodal positivity was more frequently observed in NMAA (27.6% versus 16.4%, p < 0.001). Utilization of colectomy was associated with improved DSS for NMAA patients with T2 (log rank p = 0.095) and T3 (log rank p = 0.018) tumors as well as moderately differentiated histology (log rank p = 0.006). Utilization of colectomy was not associated with improved DSS for MAA patients, which was confirmed in a multivariable model for T-stage, grade, and use of adjuvant chemotherapy [hazard ratio (HR) 1.00, 95% confidence interval (CI) 0.81-1.22].

Conclusions: Colectomy was associated with improved DSS for patients with NMAA but not MAA. Colectomy for MAA may not be required.

Citing Articles

Analysis of survival and prognostic factors in appendix adenocarcinoma and mucinous carcinoma.

Turan B, Sanli A, Acar S Updates Surg. 2025; .

PMID: 39821554 DOI: 10.1007/s13304-025-02103-6.

Predictors of Recurrence in Nonmetastatic Appendiceal Epithelial Cancers: An Updated Single-Center Experience Over 25 Years.

Aguirre N, Chung S, Foote M, Shia J, Vakiani E, Gowda T Ann Surg Oncol. 2024; 32(2):695-702.

PMID: 39604747 PMC: 11813631. DOI: 10.1245/s10434-024-16366-7.

References

Marmor S, Portschy P, Tuttle T, Virnig B . The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg. 2015; 19(4):743-50. DOI: 10.1007/s11605-014-2726-7. View

Singh H, Koomson A, Decker K, Park J, Demers A . Continued increasing incidence of malignant appendiceal tumors in Canada and the United States: A population-based study. Cancer. 2020; 126(10):2206-2216. DOI: 10.1002/cncr.32793. View

Raghav K, Shen J, Jacome A, Guerra J, Scally C, Taggart M . Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br J Cancer. 2020; 123(8):1262-1270. PMC: 7553941. DOI: 10.1038/s41416-020-1015-3. View

Glasgow S, Gaertner W, Stewart D, Davids J, Alavi K, Paquette I . The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms. Dis Colon Rectum. 2019; 62(12):1425-1438. DOI: 10.1097/DCR.0000000000001530. View

Nitecki S, Wolff B, Schlinkert R, Sarr M . The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg. 1994; 219(1):51-7. PMC: 1243090. DOI: 10.1097/00000658-199401000-00009. View

Kabbani W, Houlihan P, Luthra R, Hamilton S, Rashid A . Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol. 2002; 15(6):599-605. DOI: 10.1038/modpathol.3880572. View

Minhas A, Hendrickson J, Minhas S . Frequency and Risk Factors for Metastasis in Newly Diagnosed Appendiceal Carcinoma. Cureus. 2021; 13(7):e16341. PMC: 8357020. DOI: 10.7759/cureus.16341. View

Shannon A, Goldberg D, Song Y, Paulson E, Roses R, Fraker D . Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma. J Surg Oncol. 2020; 122(3):399-406. DOI: 10.1002/jso.25963. View

Davison J, Choudry H, Pingpank J, Ahrendt S, Holtzman M, Zureikat A . Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014; 27(11):1521-39. DOI: 10.1038/modpathol.2014.37. View

10.

Elias H, Galata C, Warschkow R, Schmied B, Steffen T, Post S . Survival after resection of appendiceal carcinoma by hemicolectomy and less radical than hemicolectomy: a population-based propensity score matched analysis. Colorectal Dis. 2017; 19(10):895-906. DOI: 10.1111/codi.13746. View

11.

AlMasri S, Hammad A, Singhi A, Paniccia A, Zureikat A, Celebrezze Jr J . Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma. Dis Colon Rectum. 2021; 66(1):67-74. PMC: 11195531. DOI: 10.1097/DCR.0000000000002089. View

12.

Straker 3rd R, Grinberg S, Sharon C, Shannon A, Fraker D, Shanmugan S . Pathologic Factors Associated with Low Risk of Lymph Node Metastasis in Nonmucinous Adenocarcinoma of the Appendix. Ann Surg Oncol. 2022; 29(4):2334-2343. DOI: 10.1245/s10434-021-11213-5. View

13.

Marks V, Kerekes D, Butensky S, Ahuja N, Johnson C, Turaga K . Role of colectomy in the management of appendiceal tumors: a retrospective cohort study. BMC Gastroenterol. 2023; 23(1):398. PMC: 10655451. DOI: 10.1186/s12876-023-03019-4. View

14.

Austin P . The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2013; 33(7):1242-58. PMC: 4285179. DOI: 10.1002/sim.5984. View

15.

Turner K, Morris M, Delman A, Hanseman D, Johnston F, Greer J . Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. J Gastrointest Surg. 2022; 26(12):2569-2578. DOI: 10.1007/s11605-022-05489-5. View

16.

Widmann B, Warschkow R, Schmied B, Marti L, Steffen T . Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis. J Gastrointest Surg. 2016; 20(8):1493-502. DOI: 10.1007/s11605-016-3148-5. View

17.

Tokunaga R, Xiu J, Johnston C, Goldberg R, Philip P, Seeber A . Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer. Clin Cancer Res. 2019; 25(10):3096-3103. PMC: 6886223. DOI: 10.1158/1078-0432.CCR-18-3388. View

18.

Ang C, Shen J, Hardy-Abeloos C, Huang J, Ross J, Miller V . Genomic Landscape of Appendiceal Neoplasms. JCO Precis Oncol. 2020; 2. PMC: 7446344. DOI: 10.1200/PO.17.00302. View

19.

Foote M, Walch H, Chatila W, Vakiani E, Chandler C, Steinruecke F . Molecular Classification of Appendiceal Adenocarcinoma. J Clin Oncol. 2022; 41(8):1553-1564. PMC: 10043565. DOI: 10.1200/JCO.22.01392. View

20.

Turaga K, Pappas S, Clark Gamblin T . Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much?. Ann Surg Oncol. 2013; 20(4):1063-7. DOI: 10.1245/s10434-012-2783-7. View